We are live on
!
Find out more
BCIM
British Columbia Investment Management Portfolio holdings
AUM
$17B
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+1.75%
1 Year Est. Return
+31.69%
3 Year Est. Return
+89.35%
5 Year Est. Return
+112.26%
10 Year Est. Return
+424.53%
AUM
$11.1B
AUM Growth
-$1.04B
(-8.6%)
Cap. Flow
-$1.11B
Cap. Flow
% of AUM
-10.03%
Top 10 Holdings %
Top 10 Hldgs %
15.54%
Holding
812
New
29
Increased
252
Reduced
388
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$27.8M |
| 3 |
Medtronic
MDT
|
+$17.5M |
| 4 |
General Motors
GM
|
+$14.8M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$78M |
| 2 |
Canadian National Railway
CNI
|
+$41.5M |
| 3 |
Brookfield
BN
|
+$40M |
| 4 |
Suncor Energy
SU
|
+$37.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$34.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.55% |
| 2 | Technology | 15.47% |
| 3 | Financials | 14.56% |
| 4 | Industrials | 10.27% |
| 5 | Consumer Staples | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Marvell Technology
MRVL
$195B
| $911K | 0.01% |
61,958
+4,964
| +9% | +$78.5K |
|
652
Core Laboratories
CLB
$571M
| $896K | 0.01% |
8,572
+3,581
| +72% | +$382K |
|
653
Franco-Nevada
FNV
$45.5B
| $889K | 0.01% |
23,200
+13,300
| +134% | +$692K |
|
654
Restaurant Brands International
QSR
$26.1B
| $873K | 0.01% |
+28,800
| New | +$1.15M |
|
655
HF Sinclair
DINO
$15.6B
| $863K | 0.01% |
21,436
+11,546
| +117% | +$443K |
|
656
RenaissanceRe
RNR
$13.2B
| $849K | 0.01% |
8,515
+729
| +9% | +$72.9K |
|
657
Ionis Pharmaceuticals
IONS
$9.39B
| $847K | 0.01% |
+13,310
| New | +$903K |
|
|
CLR
658
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $809K | 0.01% |
18,514
+8,054
| +77% | +$343K |
|
659
Gildan
GIL
$10.6B
| $806K | 0.01% |
34,600
+19,800
| +134% | +$579K |
|
660
Wheaton Precious Metals
WPM
$61.3B
| $802K | 0.01% |
53,400
+30,600
| +134% | +$651K |
|
|
GNC
661
DELISTED
GNC Holdings, Inc.
GNC
| $795K | 0.01% |
+16,200
| New | +$747K |
|
662
Telus
TU
$15B
| $794K | 0.01% |
60,508
+39,004
| +181% | +$674K |
|
663
Integer Holdings
ITGR
$4.25B
| $775K | 0.01% |
+14,700
| New | +$698K |
|
|
MNDT
664
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $764K | 0.01% |
19,457
+12,257
| +170% | +$474K |
|
665
Open Text
OTEX
$5.8B
| $756K | 0.01% |
36,200
+21,000
| +138% | +$600K |
|
|
SWI
666
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $738K | 0.01% |
+14,400
| New | +$715K |
|
|
PAY
667
DELISTED
Verifone Systems Inc
PAY
| $736K | 0.01% |
+21,100
| New | +$732K |
|
|
RKUS
668
DELISTED
RUCKUS WIRELESS INC COM STK (DE)
RKUS
| $735K | 0.01% |
+57,119
| New | +$640K |
|
669
Westlake Corp
WLK
$10.1B
| $726K | 0.01% |
+10,093
| New | +$647K |
|
670
Incyte
INCY
$24.5B
| $715K | 0.01% |
7,800
-15,801
| -67% | -$1.31M |
|
671
Myriad Genetics
MYGN
$309M
| $712K | 0.01% |
+20,100
| New | +$719K |
|
672
Regency Centers
REG
$13.9B
| $712K | 0.01% |
10,461
+5,724
| +121% | +$385K |
|
673
Agnico Eagle Mines
AEM
$93.8B
| $691K | 0.01% |
31,300
+20,300
| +185% | +$624K |
|
|
AVP
674
DELISTED
Avon Products, Inc.
AVP
| $645K | 0.01% |
80,741
-71,662
| -47% | -$595K |
|
675
United Airlines
UAL
$40.6B
| $632K | 0.01% |
9,396
| – | – |
|
Similar funds
PP
ASRS
CM
CI
EIP
BBA
FCM
British Columbia Investment Management's Q1 2015 Portfolio in Review
As of Q1 2015, British Columbia Investment Management held 812 positions worth $11.1B, down 8.6% from $12.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
British Columbia Investment Management withdrew a net $1.11B in Q1 2015, closing 99 positions and reducing 388 holdings. Its most notable exit was Allergan Inc, an estimated $78M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
Against the trend, British Columbia Investment Management opened a new position in Stratasys worth $2.64M.
- British Columbia Investment Management's largest Q1 2015 buy was Stratasys: 50,000 shares worth $2.64M.
- British Columbia Investment Management added most to Allergan plc in Q1 2015, an estimated $47M increase.
- British Columbia Investment Management's biggest Q1 2015 reduction was Canadian National Railway, cutting an estimated $41.5M.
- British Columbia Investment Management fully exited Allergan Inc in Q1 2015, selling an estimated $78M.
- British Columbia Investment Management's ten largest holdings make up 16% of its $11.1B portfolio in Q1 2015.
- British Columbia Investment Management opened 29 new positions and closed 99 in Q1 2015.
- British Columbia Investment Management's portfolio value fell 8.6% quarter-over-quarter to $11.1B.
Based on British Columbia Investment Management's 13F filing for Q1 2015, filed 5 May 2015.